Literature DB >> 12391224

Modulation of gene expression by the MHC class II transactivator.

Uma M Nagarajan1, Alyssa Bushey, Jeremy M Boss.   

Abstract

The class II transactivator (CIITA) is a master regulator of MHC class II expression. CIITA also modulates the expression of MHC class I genes, suggesting that it may have a more global role in gene expression. To determine whether CIITA regulates genes other than the MHC class II and I family, DNA microarray analysis was used to compare the expression profiles of the CIITA expressing B cell line Raji and its CIITA-negative counterpart RJ2.2.5. The comparison identified a wide variety of genes whose expression was modulated by CIITA. Real time RT-PCR from Raji, RJ2.2.5, an RJ2.2.5 cell line complemented with CIITA, was performed to confirm the results and to further identify CIITA-regulated genes. CIITA-regulated genes were found to have diverse functions, which could impact Ag processing, signaling, and proliferation. Of note was the identification of a set of genes localized to chromosome 1p34-35. The global modulation of genes in a local region suggests that this region may share some regulatory control with the MHC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391224     DOI: 10.4049/jimmunol.169.9.5078

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Coexpression of MAST205 inhibits the activity of Na+/H+ exchanger NHE3.

Authors:  Dongsheng Wang; Hye Jeong Lee; Deborah S Cooper; Ludmila Cebotaro; Paul D Walden; Inyeong Choi; C Chris Yun
Journal:  Am J Physiol Renal Physiol       Date:  2005-09-13

Review 2.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Host chemokine and cytokine response in the endocervix within the first developmental cycle of Chlamydia muridarum.

Authors:  Roger G Rank; H Marie Lacy; Anna Goodwin; James Sikes; Judy Whittimore; Priscilla B Wyrick; Uma M Nagarajan
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

4.  Differential signaling pathways are initiated in macrophages during infection depending on the intracellular fate of Chlamydia spp.

Authors:  Uma M Nagarajan; Manoj Tripathy; Avinash Kollipara; John Allen; Anna Goodwin; Judy Whittimore; Priscilla B Wyrick; Roger G Rank
Journal:  Immunol Cell Biol       Date:  2018-01-06       Impact factor: 5.126

5.  Molecular characterization of chicken class II transactivator gene.

Authors:  Gholamreza Nikbakht Brujeni; Mohammad Khosravi
Journal:  Immunogenetics       Date:  2014-10-24       Impact factor: 2.846

6.  Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

Authors:  T Rodríguez; R Méndez; A Del Campo; N Aptsiauri; J Martín; G Orozco; G Pawelec; D Schadendorf; F Ruiz-Cabello; F Garrido
Journal:  Immunogenetics       Date:  2006-12-20       Impact factor: 2.846

7.  Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B.

Authors:  Ying-Ren Zhao; Ling Gong; Ying-Li He; Fang Liu; Chang Lu
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

8.  Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.

Authors:  Pritam Sengupta; Yong Xu; Lin Wang; Russell Widom; Barbara D Smith
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

9.  Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.

Authors:  Yeong Shin Lee; Soo Hyun Kim; Jung Ah Cho; Chul Woo Kim
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 10.  PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice.

Authors:  Wiljan J A J Hendriks; Gönül Dilaver; Yvet E Noordman; Berry Kremer; Jack A M Fransen
Journal:  Cerebellum       Date:  2009-01-10       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.